A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RAM / risk assessment model

[Related PubMed/MEDLINE]
Total Number of Papers: 52
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RAM  (>> Co-occurring Abbreviation)
Long Form:   risk assessment model
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Assessing the Risk for Development of Deep Vein Thrombosis among Chinese Patients using the 2010 Caprini Risk Assessment Model: A Prospective Multicenter Study. DVT
2020 Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study. KS, VTE
2020 Comparison of 2013 and 2009 versions of Caprini risk assessment models for predicting VTE in Chinese cancer patients: a retrospective study. AUC, ROC, VTE
2020 Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the CHAT Consortium. AUROC, CHAT, HA-VTE
2020 External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolismin the Padua cohort. CI, HR, VTE
2020 Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer. CAT, KRS, VTE
2020 Paraneoplastic Thromboembolism and Thrombophilia: Significance in Visceral Medicine. ATE, DOAC, GI, LMWH, SVT
2020 The Application of Gail Model to Predict the Risk of Developing Breast Cancer among Jordanian Women. ---
2019 A novel risk assessment model for venous thromboembolism after major thoracic surgery: a Chinese single-center study. CTPA, DVT, PE, ROC, VTE
10  2019 Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies. VTE
11  2019 Appropriateness of deep vein thrombosis (DVT) prophylaxis use among medical inpatients: a DVT risk alert tool (DRAT) study. DRAT, DVT, IMPROVE, VTE
12  2019 Completion of the Updated Caprini Risk Assessment Model (2013 Version). ---
13  2019 Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma. HRs, MM, VTE
14  2019 Determination of Risk Factors for Venous Thromboembolism by an Adapted Caprini Scoring System in Surgical Patients. VTE
15  2019 Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis. VTE
16  2019 Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU). COPDE, IMV
17  2019 Venous thromboembolism risk and prophylaxis prescription in surgical patients at a tertiary hospital in Eastern Cape Province, South Africa. SA, VTE
18  2018 Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model. PPS, VTE
19  2018 Caprini Risk Model Decreases Venous Thromboembolism Rates in Thoracic Surgery Cancer Patients. VTE
20  2018 Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative care. DVT, ICU, PE, VTE
21  2018 Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative care. DVT, ICU, PE, SICU, VTE
22  2018 Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study. ETP, NDMM, Procoagulant-PPL, TFPI, VTE
23  2018 Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study. FV, FVIIa, MRI, Procoag-PPL, TFa, VTE
24  2018 Risk assessment as a guide for the prevention of cancer-associated thromboembolism. VTE
25  2018 Updated clinical models for VTE prediction in hospitalized medical patients. IMPROVE-RAM, PPS, VTE
26  2018 Venous thromboembolism events after breast reconstructions with DIEP free flaps in 192 consecutive case. DIEP, VTE
27  2017 A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study. COMPASS-CAT, LMWH, VTE
28  2017 Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review. VTE
29  2016 Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study. AUC, ROC, VTE
30  2016 Derivation of a risk assessment model for hospital-acquired venous thrombosis: the NAVAL score. CI, NRI, VT
31  2016 Estimating Risk of Venous-Thromboembolic Events in Hospitalized Medical Patients: Comparison between 2008 and 2012 Guidelines. ACCP, VTEs
32  2016 External validation of the IMPROVE Bleeding Risk Assessment Model in medical patients. OR
33  2016 PO-53 - Prospective evaluation of risk assessment models and biological markers of hypercoagulability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study. CG, DDi, HB, HPA, LA, MTS, PPL, TFa, TG
34  2016 Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol. VTE
35  2015 Creation and validation of a condition-specific venous thromboembolism risk assessment tool for ventral hernia repair. DVT, VHR, VTE
36  2015 Evaluation of the Caprini Model for Venothromboembolism in Esophagectomy Patients. VTE
37  2014 Developing best practices to study trauma outcomes in large databases: an evidence-based approach to determine the best mortality risk adjustment model. CI, GCS, ISS, NTDB
38  2014 External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR). CI, VTE
39  2014 Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability. PDMP, PPL-ct, TG
40  2014 Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients. OR, SICU, VTE
41  2014 Predicting recurrent venous thromboembolism in cancer: is it possible? VTE
42  2014 The Use of VTE prophylaxis in relatioN to patiEnt risk profiling (TUNE-IN) Wave 2 study. VTE
43  2014 Validation of a venous thromboembolism risk assessment model in gynecologic oncology. DVT, PE, VTE
44  2014 Validation of a venous thromboembolism risk assessment model in hospitalized chinese patients: a case-control study. VTE
45  2012 DVT prophylaxis in relation to patient risk profiling - TUNE-IN study. VTE
46  2012 Venous thromboembolism in abdominoplasty: a comprehensive approach to lower procedural risk. DVT, VTE
47  2011 Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. AUC, CI, VTE
48  2011 Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. DVT, OR, PE, VTE, VTEPS
49  2011 [Thromboprophylaxis: medical recommendations and hospital programs]. VTE
50  2010 A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. HR, VTE
51  2010 The use of an exclusion-based risk-assessment model for venous thrombosis improves uptake of appropriate thromboprophylaxis in hospitalized medical patients. ---
52  2006 Evidence for the prevention of venous thromboembolism. VTE